CAMPOMENOSI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 6.989
EU - Europa 4.119
AS - Asia 2.795
SA - Sud America 348
AF - Africa 58
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 11
Totale 14.335
Nazione #
US - Stati Uniti d'America 6.799
IT - Italia 1.932
SG - Singapore 830
CN - Cina 638
UA - Ucraina 527
VN - Vietnam 391
DE - Germania 351
TR - Turchia 335
HK - Hong Kong 304
BR - Brasile 290
SE - Svezia 290
RU - Federazione Russa 188
FI - Finlandia 187
GB - Regno Unito 174
IE - Irlanda 144
CA - Canada 133
FR - Francia 132
IN - India 75
MX - Messico 44
JP - Giappone 42
NL - Olanda 42
ES - Italia 40
BD - Bangladesh 28
PL - Polonia 26
BE - Belgio 22
IQ - Iraq 22
AR - Argentina 19
ZA - Sudafrica 19
KR - Corea 16
PK - Pakistan 15
AU - Australia 14
IR - Iran 13
CZ - Repubblica Ceca 12
EU - Europa 10
KE - Kenya 10
AE - Emirati Arabi Uniti 9
CO - Colombia 9
EC - Ecuador 9
LT - Lituania 9
AT - Austria 8
TW - Taiwan 8
CL - Cile 7
MY - Malesia 7
PH - Filippine 7
TH - Thailandia 7
ID - Indonesia 6
LB - Libano 6
MA - Marocco 6
RO - Romania 6
VE - Venezuela 6
DZ - Algeria 5
UZ - Uzbekistan 5
CH - Svizzera 4
DK - Danimarca 4
EE - Estonia 4
EG - Egitto 4
JO - Giordania 4
NG - Nigeria 4
OM - Oman 4
TN - Tunisia 4
AZ - Azerbaigian 3
CI - Costa d'Avorio 3
NO - Norvegia 3
NP - Nepal 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
BO - Bolivia 2
HN - Honduras 2
HU - Ungheria 2
IS - Islanda 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LU - Lussemburgo 2
PE - Perù 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
MG - Madagascar 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
PR - Porto Rico 1
PS - Palestinian Territory 1
Totale 14.331
Città #
Milan 1.180
Fairfield 612
Ashburn 562
San Jose 522
Chandler 460
Singapore 458
Jacksonville 426
Woodbridge 394
Houston 314
Dallas 297
Hong Kong 297
Ann Arbor 258
Seattle 258
Wilmington 246
Cambridge 192
Beijing 186
Como 179
Princeton 153
Nyköping 149
The Dalles 145
Dublin 143
Izmir 138
Dearborn 131
Boardman 125
New York 125
Dong Ket 111
Los Angeles 97
Toronto 94
Chicago 88
Lauterbourg 77
Rome 72
Kocaeli 61
Munich 56
San Diego 50
Ho Chi Minh City 47
Ponte Lambro 47
London 43
Moscow 41
Orem 41
San Mateo 40
Santa Clara 40
Hanoi 39
Council Bluffs 37
Helsinki 34
Ogden 34
Tokyo 34
Guangzhou 33
Denver 29
Des Moines 29
São Paulo 29
Varese 28
Düsseldorf 26
Chennai 24
Warsaw 24
Montreal 23
Amsterdam 22
Langenfeld 22
Mexico City 22
Buffalo 21
Falls Church 21
Frankfurt am Main 21
Phoenix 21
Turku 21
Nanjing 20
Brussels 19
Gallarate 19
Manchester 19
Shanghai 18
Hangzhou 16
Nuremberg 16
Brooklyn 15
Johannesburg 15
Stockholm 15
Atlanta 14
Hefei 14
Washington 14
Mumbai 13
Da Nang 12
Poplar 12
Salt Lake City 11
San Francisco 11
Redwood City 10
Haiphong 9
Nairobi 9
Querétaro 9
Verona 9
Baghdad 8
Boston 8
Busto Arsizio 8
Jinan 8
Norwalk 8
Redmond 8
Auburn Hills 7
Bangkok 7
Berlin 7
Charlotte 7
Omaha 7
Rio de Janeiro 7
Brno 6
Changsha 6
Totale 9.970
Nome #
A comparison between quantitative PCR and droplet digital PCR technologies for circulating microRNA quantification in human lung cancer 319
Proline Dehydrogenase affects Lung Adenocarcinoma cell survival, proliferation, and 3D growth 301
Characterization of RNASET2, the first human member of the Rh/T2/S family of glycoproteins 284
Proteomic analysis of MG132-treated germinating pollen reveals expression signatures associated with proteasome inhibition 268
Systematic review and critique of circulating miRNAs as biomarkers of stage I-II non-small cell lung cancer. 255
Proline Dehydrogenase affects lung cancer cell proliferation by inducing ROS and cellular senescence 235
Effect of inulin on proteome changes induced by pathogenic lipopolysaccharide in human colon 229
Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase. 225
Comparison of the baculovirus-insect cell and Pichia pastoris heterologous systems for the expression of the human tumor suppressor protein RNASET2 224
Abstract 3402: ΔN-p63α and TA-p63α exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites 219
TAS2R38 taste receptor gene and chronic rhinosinusitis: new data from an Italian population 219
Biochemical and immunohistochemical characterization of human RNASET2 expression 216
Defective splicing induced by 4NQO in the hamster hprt gene. 209
5-methylcytosine at HpaII sites in p53 is not hypermutable after UVC irradiation. 209
The degradation (by distinct pathways) of human D-amino acid oxidase and its interacting partner pLG72--two key proteins in D-serine catabolism in the brain. 208
TAS2R38 taste receptor gene and chronic rhinosinusitis: a bitter ending 208
Analysis of stepwise genetic changes in an AIDS-related Burkitt's lymphoma 205
Proline oxidase controls proline, glutamate, and glutamine cellular concentrations in a U87 glioblastoma cell line 204
Derivative chromosome 17 in a case of Burkitt lymphoma with 8;14 translocation. 200
Expression of proline dehydrogenase in non-small cell lung cancer: immunohistochemical characterization and possible regulators. 200
TRP channels expression in Chronic Low Back Pain 199
Analysis of 4-nitroquinoline-1-oxide induced mutations at the hprt locus in mammalian cells: possible involvement of preferential DNA repair. 198
Emerging role of Proline dehydrogenase in 2D and 3D growth of lung cancer cells resistant to tyrosine kinase inhibitors 197
Defective nuclear localization of p53 protein in a Chinese hamster cell line is associated with the formation of stable cytoplasmic protein multimers in cells with gene amplification. 194
Unravelling the role of proline dehydrogenase (PRODH) in lung adenocarcinoma: implications for cellular senescence and the tumor microenvironment 192
ΔN-p63a and ta-p63a exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites 192
Microenvironment-mediated regulation of cancer growth by the human RNASET2 oncosuppressor gene 191
Characterization of the p53 mutants ability to inhibit p73b transactivation using a yeast-based functional assay 187
Characterization of the p53 mutants ability to inhibit p73 beta transactivation using a yeast-based functional assay 186
Serum miR-223: a validated biomarker for detection of early-stage non-small cell lung cancer 186
Cellular and biochemical characterization of the human member of Rh/T2/S ribonucleases 177
Nucleotide excision repair defect influences lethality and mutagenicity induced by Me-lex, a sequence-selective N3-adenine methylating agent in the absence of base excision repair 177
A dual role of Proline Dehydrogenase in Lung Cancer 176
P53 family members modulate the expression of PRODH, but not PRODH2, via intronic p53 response elements 175
Caratterizzazione strutturale e funzionale di rnase6pl, un putativo gene oncosoppressore localizzato sul cromosoma 6 umano 171
Tumour p53 mutations exhibit promoter selective dominance over wild type p53 170
Protective effect of inulin on LPS-induced intestinal smooth muscle impairment: a proteomic approach. 170
Lack of mutations in K-ras codons 12 and 13 in human atherosclerotic lesions. 169
Gadd45 mutations are uncommon in human tumour cell lines 166
Prediction and experimental validation of natural antisense transcripts in two cancer-associated regions of human chromosome 6 164
p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements 164
Analysis of K-ras, p53, bcl-2 and Rb expression in non-small cell lung cancer cell lines. 164
Signals of pseudo-starvation unveil the amino acid transporter SLC7A11 as key determinant in the control of Treg cell proliferative potential 162
Proline Dehydrogenase as a player in acquired resistance to Tyrosine Kinase Inhibitors 160
Influences of base excision repair defects on the lethality and mutagenicity induced by Me-lex, a sequence-selective N3-Adenine methylating agent 160
Molecular characterization of RNASE6PL, a putative human tumor suppressor gene on chromosome 6q27. 159
Amifostine (WR2721) restores transcriptional activity of speci®c p53mutant proteins in a yeast functional assay 159
∆N-P63α and TA-P63α exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites. 154
N-(2-chloroethyl)-N-nitrosourea tethered to lexitropsin induces minor groove lesions at the p53 cDNA that are more cytotoxic than mutagenic. 149
STUDIO FUNZIONALE DI RNASE6PL, PUTATIVO GENE ONCOSOPRESSORE LOCALIZZATO IN 6Q27 146
p53 mutations and DNA ploidy in colorectal adenocarcinomas. 146
Cancer biomarkers in human atherosclerotic lesions: no evidence of p53 involvement. 145
Heterogeneous p53 mutations in a Burkitt lymphoma from an AIDS patient with monoclonal c-myc and VDJ rearrangements. 145
TRPV4 and TRPM8 as putative targets for chronic low back pain alleviation 142
Influences of nucleotide and base excision repair defects on the lethality and mutagenicity induced by Me-lex, a sequence selective N3-adenine methylating agent 141
The 4-nitroquinoline 1-oxide mutational spectrum in single stranded DNA is characterized by guanine to pyrimidine transversions. 140
Mutation spectrum of 4-nitroquinoline 1-oxide-damaged single-stranded shuttle vector DNA transfected into monkey cells. 137
PROLINE DEHYDROGENASE EXPRESSION, REGULATION AND FUNCTION IN NON-SMALL CELL LUNG CARCINOMA 136
p53 mutations experimentally induced by 8-methoxypsoralen plus UVA (PUVA) differ from those found in human skin cancers in PUVA-treated patients. 135
Human Primary Dermal Fibroblasts Interacting with 3-Dimensional Matrices for Surgical Application Show Specific Growth and Gene Expression Programs 135
Tumor and metastasis suppression by the human RNASET2 gene. 133
RNASET2, a human tumor antagonizing gene supressing tumor growth in vivo but not in vitro 130
Measurements Methods for the Development of MicroRNA-Based Tests for Cancer Diagnosis. 129
Influences of nucleotide and base excision repair defects on the lethality and mutagenicity induced by Me-lex, a sequence selective N3-adenine methylating agent. 125
Mutational fingerprint induced by the antineoplastic drug chloroethyl-cyclohexyl-nitrosourea in mammalian cells. 122
Stable formation of mutated p53 multimers in a Chinese hamster cell line causes defective p53 nuclear localization and abrogates its residual function. 121
The in vivo tumor antagonizing role of human RNASET2 is mediated by host stromal cells recruitment 121
p53 is frequently mutated in Barrett's metaplasia of the intestinal type. 121
The yeast p53 functional assay: a new tool for molecular epidemiology. Hopes and facts. 121
RNASET2 is a non-cell autonomous human tumor suppressor 119
Rnaset2, the first human ribonuclease of the rh/t2/s family, displays a role in tumor suppression 118
Study on aneuploidy and p53 mutations in astrocytomas. 118
Proline Dehydrogenase (PRODH) Is Expressed in Lung Adenocarcinoma and Modulates Cell Survival and 3D Growth by Inducing Cellular Senescence 117
Partial characterization of SUVi, a new mammalian gene induced by UV-C and expressed during the S phase of the cell cycle 115
Beyond conventional: The new horizon of anti-angiogenic micrornas in non-small cell lung cancer therapy 115
Study of 4-NQO induced mutations at the HPRT locus in CHO cell lines. Possible influences of preferential DNA-repair on the mutational spectrum. 112
Serum miRNAs as biomarkers for early diagnosis of non small cell lung cancer 110
FUNCTIONAL CHARACTERIZATION OF P53 MUTANT PROTEINS: A WAY FOR UNDERSTANDING THEIR ROLE IN CARCINOGENESIS 109
Multi-system approach to study mutagenesis induced by chemical carcinogens. 102
Mutation of p53 in the progression of Barrett's epithelium to invasive esophageal cancer: A prospective study 101
Single stranded DNA-vectors for analyzing processing of DNA damage induced by 4-nitroquinoline-1-oxide in prokaryotes and eukaryotes. 100
RNASET2, a putative oncosuppressor gene: cellular and biochemical characterization 95
Genetic alterations in astrocytic tumors: hints to a molecular epidemiological interpretation. 95
Proline Dehydrogenase as new marker and target in EGFR mutant Non-Small Cell Lung carcinoma 93
RNASET2 is the first ribonuclease of the Rh/T2/S family discovered in humans and displays unusual roles in tumor suppression. 85
The role of the medicinal leech HvRNASET2 enzyme during tissue remodeling 76
The medicinal leech HvRNASET2 enzyme as a promising molecule during tissue regeneration 69
The Potential Role of the T2 Ribonucleases in TME-Based Cancer Therapy 60
MiR-223-3p in Cancer Development and Cancer Drug Resistance: Same Coin, Different Faces 56
Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study 46
MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis 42
Totale 14.429
Categoria #
all - tutte 51.006
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.006


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021502 0 0 0 0 0 0 0 0 0 173 117 212
2021/2022921 124 129 52 39 38 37 62 70 65 124 68 113
2022/20231.244 104 75 88 147 83 268 69 155 131 41 45 38
2023/20241.763 283 268 265 299 329 145 20 26 58 8 15 47
2024/20251.910 10 17 223 71 203 135 130 176 240 156 160 389
2025/20263.903 347 235 352 639 476 282 694 320 354 204 0 0
Totale 14.429